Marta I. Yurda-Lopez
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.
Journal: Clinical and translational radiation oncology
Published: January 07, 2026
Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial.
Journal: Gynecologic oncology
Published: January 07, 2026
MRI in advanced ovarian cancer: multicentre MISSION trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 01, 2025
Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 04, 2025
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 30, 2025
Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 04, 2025
Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.
Journal: EJNMMI research
Published: February 01, 2025
Return to work after neoadjuvant versus adjuvant immunotherapy in stage III melanoma patients.
Journal: Journal of cancer survivorship : research and practice
Published: January 31, 2025
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 23, 2025
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial.
Journal: Nature communications
Published: October 22, 2024
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 10, 2024
Last Updated: 09/26/2026